I investigated the anti-tumor effects of nodakenin in vivo and in vitro and showed that nodakenin exerts a powerful anti-cancer effect via the inhibition of cell viability and tumor volume and the enhancement of caspase-3 activity and LDH cytotoxicity. This evidence concerns the gene CASP3 and cancer.